Economic Evaluation of Ciprofloxacin Compared with Usual Antibacterial Care for the Treatment of Acute Exacerbations of Chronic Bronchitis in Patients Followed for 1 Year

@article{Torrance1999EconomicEO,
  title={Economic Evaluation of Ciprofloxacin Compared with Usual Antibacterial Care for the Treatment of Acute Exacerbations of Chronic Bronchitis in Patients Followed for 1 Year},
  author={George W. Torrance and Ms Valery Walker and Ronald F Grossman and Jayanti Mukherjee and David Vaughan and Jacques La Forge and Noel Lampron},
  journal={PharmacoEconomics},
  year={1999},
  volume={16},
  pages={499-520}
}
Objective: To undertake a 1-year prospective economic evaluation of ciprofloxacin compared with usual antibacterial care (any antibacterial other than a quinolone) for the treatment of acute exacerbations of chronic bronchitis (AECB) in adults presenting with a type I or type II AECB. Design: Patients entered the study with an initial AECB and were randomised to the ciprofloxacin group or the usual care group. The following measurements were taken at the end of each AECB and every 3 months… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 30 references

Methods for the economic evaluation of health care programmes. 2nd ed

  • MF Drummond, BJ O’Brien, GL Stoddart
  • 1997
Highly Influential
6 Excerpts

Including a generic quality of life measure with a disease-specific measure in an asthma clinical trial: advantages and disadvantages [abstract

  • N. Santanello
  • Drug Inf J
  • 1993
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…